Ubiquitin conjugation and deconjugation in nf-κb signaling

Sub-Cellular Biochemistry

Volumn 54, Issue , 2010, Pages 88-99

  Düwel, Michael ^a   Hadian, Kamyar ^a   Krappmann, Daniel ^b  

^a Helmholtz Zentrum München German Research Center for Environmental Health Institute of Toxicology Department Cellular Signal Integration ^*

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UBIQUITIN;

HUMAN; METABOLISM; SIGNAL TRANSDUCTION; UBIQUITINATION;

HUMANS; I-KAPPA B KINASE; NF-KAPPA B; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITINATION;

EID: 84867155490     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4419-6676-6_7     Document Type: Article

References (85)

1. Hayden, M.S., Ghosh, S. (2008) Shared principles in NF-kappaB signaling. Cell 132: pp. 344-62
2. Ghosh, S., Hayden, M.S. (2008) New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8: pp. 837-48
3. Vallabhapurapu, S., Karin, M. (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: pp. 693-733
4. Scheidereit, C. (2006) IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25: pp. 6685-705
5. Ikeda, F., Dikic, I. (2008) Atypical ubiquitin chains: new molecular signals. ‘Protein Modifications: Beyond the Usual Suspects’ review series. EMBO Rep 9: pp. 536-42
6. Komander, D., Clague, M.J., Urbe, S. (2009) Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10: pp. 550-63
7. Jackson, P.K., Eldridge, A.G. (2002) The SCF ubiquitin ligase: an extended look. Mol Cell 9: pp. 923-5
8. Hoffmann, A., Natoli, G., Ghosh, G. (2006) Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25: pp. 6706-16
9. Chen, Z.J., Parent, L., Maniatis, T. (1996) Site-specific phosphorylation of IkappaBalpha by a novel ubiquitinationdependent protein kinase activity. Cell 84: pp. 853-62
10. Bhoj, V.G., Chen, Z.J. (2009) Ubiquitylation in innate and adaptive immunity. Nature 458: pp. 430-7
11. Tokunaga, F., Sakata, S., Saeki, Y. (2009) Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 11: pp. 123-32
12. Lo, Y.C., Lin, S.C., Rospigliosi, C.C. (2009) Structural basis for recognition of diubiquitins by NEMO. Mol Cell 33: pp. 602-15
13. Rahighi, S., Ikeda, F., Kawasaki, M. (2009) Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136: pp. 1098-109
14. Yoshikawa, A., Sato, Y., Yamashita, M. (2009) Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin. FEBS Lett 583: pp. 3317-22
15. Laplantine, E., Fontan, E., Chiaravalli, J. (2009) NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J 28: pp. 2885-95
16. Besse, A., Lamothe, B., Campos, A.D. (2007) TAK1-dependent signaling requires functional interaction with TAB2/TAB3. J Biol Chem 282: pp. 3918-28
17. Ishitani, T., Takaesu, G., Ninomiya-Tsuji, J. (2003) Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J 22: pp. 6277-88
18. Kanayama, A., Seth, R.B., Sun, L. (2004) TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell 15: pp. 535-48
19. Sato, S., Sanjo, H., Takeda, K. (2005) Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6: pp. 1087-95
20. Shim, J.H., Xiao, C., Paschal, A.E. (2005) TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 19: pp. 2668-81
21. Wan, Y.Y., Chi, H., Xie, M. (2006) The kinase TAK1 integrates antigen and cytokine receptor signaling for T-cell development, survival and function. Nat Immunol 7: pp. 851-8
22. Wang, C., Deng, L., Hong, M. (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: pp. 346-51
23. Xia, Z.P., Sun, L., Chen, X. (2009) Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461: pp. 114-9
24. Li, X., Qin, J. (2005) Modulation of Toll-interleukin 1 receptor mediated signaling. J Mol Med 83: pp. 258-66
25. Xu, M., Skaug, B., Zeng, W. (2009) A Ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta. Mol Cell 36: pp. 302-14
26. Deng, L., Wang, C., Spencer, E. (2000) Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: pp. 351-61
27. Lomaga, M.A., Yeh, W.C., Sarosi, I. (1999) TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40 and LPS signaling. Genes Dev 13: pp. 1015-24
28. Takeda, K., Akira, S. (2004) TLR signaling pathways. Semin Immunol 16: pp. 3-9
29. Park, Y.C., Burkitt, V., Villa, A.R. (1999) Structural basis for self-association and receptor recognition of human TRAF2. Nature 398: pp. 533-8
30. Yin, Q., Lin, S.C., Lamothe, B. (2009) E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol 16: pp. 658-66
31. Conze, D.B., Wu, C.J., Thomas, J.A. (2008) Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor-and toll-like receptor-mediated NF-kappaB activation. Mol Cell Biol 28: pp. 3538-47
32. Windheim, M., Stafford, M., Peggie, M. (2008) Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase. Mol Cell Biol 28: pp. 1783-91
33. Yamamoto, M., Okamoto, T., Takeda, K. (2006) Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat Immunol 7: pp. 962-70
34. Bidere, N., Snow, A.L., Sakai, K. (2006) Caspase-8 regulation by direct interaction with TRAF6 in T-cell receptor-induced NF-kappaB activation. Curr Biol 16: pp. 1666-71
35. Oeckinghaus, A., Wegener, E., Welteke, V. (2007) Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J 26: pp. 4634-45
36. Sun, L., Deng, L., Ea, C.K. (2004) The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T-lymphocytes. Mol Cell 14: pp. 289-301
37. Yamamoto, M., Sato, S., Saitoh, T. (2006) Cutting Edge: Pivotal function of Ubc13 in thymocyte TCR signaling. J Immunol 177: pp. 7520-4
38. King, C.G., Kobayashi, T., Cejas, P.J. (2006) TRAF6 is a T-cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nat Med 12: pp. 1088-92
39. Wu, C.J., Ashwell, J.D. (2008) NEMO recognition of ubiquitinated Bcl10 is required for T-cell receptor-mediated NF-kappaB activation. Proc Natl Acad Sci USA 105: pp. 3023-8
40. Hu, S., Du, M.Q., Park, S.M. (2006) et al cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. J Clin Invest 116: pp. 174-81
41. Reiley, W.W., Jin, W., Lee, A.J. (2007) Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T-cell responses. J Exp Med 204: pp. 1475-85
42. Sorrentino, A., Thakur, N., Grimsby, S. (2008) The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10: pp. 1199-207
43. Ea, C.K., Deng, L., Xia, Z.P. (2006) Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22: pp. 245-57
44. Li, H., Kobayashi, M., Blonska, M. (2006) Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem 281: pp. 13636-43
45. Wu, C.J., Conze, D.B., Li, T. (2006) Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol 8: pp. 398-406
46. Funakoshi-Tago, M., Kamada, N., Shimizu, T. (2009) TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation. Cytokine 45: pp. 72-9
47. Tada, K., Okazaki, T., Sakon, S. (2001) Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J Biol Chem 276: pp. 36530-4
48. Yin Q, Lamothe B, Darnay BG et al. Structural Basis for the Lack of E2 Interaction in the RING Domain of TRAF2. Biochemistry 2009.
49. Mahoney, D.J., Cheung, H.H., Mrad, R.L. (2008) Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci USA 105: pp. 11778-83
50. Varfolomeev, E., Goncharov, T., Fedorova, A.V. (2008) c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem 283: pp. 24295-9
51. Bignell, G.R., Warren, W., Seal, S. (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25: pp. 160-5
52. Brummelkamp, T.R., Nijman, S.M., Dirac, A.M. (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424: pp. 797-801
53. Kovalenko, A., Chable-Bessia, C., Cantarella, G. (2003) The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424: pp. 801-5
54. Trompouki, E., Hatzivassiliou, E., Tsichritzis, T. (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424: pp. 793-6
55. Jin, W., Chang, M., Paul, E.M. (2008) Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J Clin Invest 118: pp. 1858-66
56. Wright, A., Reiley, W.W., Chang, M. (2007) Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD. Dev Cell 13: pp. 705-16
57. Yoshida, H., Jono, H., Kai, H. (2005) The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J Biol Chem 280: pp. 41111-21
58. Komander, D., Lord, C.J., Scheel, H. (2008) The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module. Mol Cell 29: pp. 451-64
59. Komander, D., Reyes-Turcu, F., Licchesi, J.D. (2009) Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep 10: pp. 466-73
60. Jono, H., Lim, J.H., Chen, L.F. (2004) NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem 279: pp. 36171-4
61. Hutti, J.E., Shen, R.R., Abbott, D.W. (2009) Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol Cell 34: pp. 461-72
62. Reiley, W., Zhang, M., Wu, X. (2005) Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation. Mol Cell Biol 25: pp. 3886-95
63. Massoumi, R., Chmielarska, K., Hennecke, K. (2006) Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell 125: pp. 665-77
64. Reiley, W.W., Zhang, M., Jin, W. (2006) Regulation of T-cell development by the deubiquitinating enzyme CYLD. Nat Immunol 7: pp. 411-7
65. Boone, D.L., Turer, E.E., Lee, E.G. (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5: pp. 1052-60
66. Lee, E.G., Boone, D.L., Chai, S. (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: pp. 2350-4
67. Turer, E.E., Tavares, R.M., Mortier, E. (2008) Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20. J Exp Med 205: pp. 451-64
68. Wertz, I.E., O’Rourke, K.M., Zhou, H. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: pp. 694-9
69. Shembade, N., Harhaj, N.S., Parvatiyar, K. (2008) The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat Immunol 9: pp. 254-62
70. Shembade, N., Parvatiyar, K., Harhaj, N.S. (2009) The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling. EMBO J 28: pp. 513-22
71. Stilo, R., Varricchio, E., Liguoro, D. (2008) A20 is a negative regulator of BCL10-and CARMA3-mediated activation of NF-kappaB. J Cell Sci 121: pp. 1165-71
72. Komander, D., Barford, D. (2008) Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem J 409: pp. 77-85
73. Lin, S.C., Chung, J.Y., Lamothe, B. (2008) Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. J Mol Biol 376: pp. 526-40
74. Werner, S.L., Kearns, J.D., Zadorozhnaya, V. (2008) Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20. Genes Dev 22: pp. 2093-101
75. Li, L., Hailey, D.W., Soetandyo, N. (2008) Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling. Biochim Biophys Acta 1783: pp. 1140-9
76. Hutti, J.E., Turk, B.E., Asara, J.M. (2007) IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Mol Cell Biol 27: pp. 7451-61
77. Coornaert, B., Baens, M., Heyninck, K. (2008) T-cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat Immunol 9: pp. 263-71
78. Duwel, M., Welteke, V., Oeckinghaus, A. (2009) A20 negatively regulates T-cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J Immunol 182: pp. 7718-28
79. Vereecke, L., Beyaert, R., Loo, G. (2009) The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 30: pp. 383-91
80. Compagno, M., Lim, W.K., Grunn, A. (2009) Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459: pp. 717-21
81. Kato, M., Sanada, M., Kato, I. (2009) Frequent inactivation of A20 in B-cell lymphomas. Nature 459: pp. 712-6
82. Ferch, U., Kloo, B., Gewies, A. (2009) Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 206: pp. 2313-20
83. Evans, P.C., Taylor, E.R., Coadwell, J. (2001) Isolation and characterization of two novel A20-like proteins. Biochem J 357: pp. 617-23
84. Enesa, K., Zakkar, M., Chaudhury, H. (2008) NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J Biol Chem 283: pp. 7036-45
85. Schweitzer, K., Bozko, P.M., Dubiel, W. (2007) CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha. EMBO J 26: pp. 1532-41